Richard Wright, MD, board-certified cardiologist at Providence Saint Johns Health Center in Santa Monica, CA, not involved in this research, commented on the trial results for Medical News Today
Objective: To investigate whether liraglutide 3.0 mg reduces OSA severity compared with placebo using the primary end point of change in apneahypopnea index (AHI) after 32 weeks
One of the most talked about is pancreatitis, an inflammation of the pancreas
What makes SLU-PP-332 unique among ERR agonists
2,3 GLP-1 controls blood glucose by stimulating insulin secretion, inhibiting glucagon secretion, stimulating beta-cell proliferation and differentiation, decreasing beta-cell apoptosis, delaying gastric emptying, and reducing food intake
Those conversations can improve confidence, help patients navigate challenges, and ultimately make the difference in terms of treatment adherence and success. GLP-1 RAs should always be embedded within ongoing, holistic weight-management care, she said